## TSN: Tyson Foods, Inc. - XLP: Consumer Defensive

### Executive Summary

VALUE thesis: PEG 0.33 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-5.7% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($54.16)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 5
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Tyson agrees to $82.5M settlement in beef price-fixing lawsuit**
- Source: Food Dive | 20260106T171249 | Somewhat-Bearish | Relevance: 100%
- Tyson Foods has agreed to an $82.5 million settlement in a class-action lawsuit alleging illegal beef price inflation between 2015 and 2021. This settlement follows similar agreements by Tyson in other price-fixing lawsuits related to beef and pork, as meat giants face numerous claims from consumers, distributors, and grocers. The agreement awaits judicial approval and highlights ongoing scrutiny of pricing practices in the meat industry.

**2. Tyson Foods Announces First Quarter Earnings Conference Call and Webcast**
- Source: The Manila Times | 20260105T221126 | Neutral | Relevance: 100%
- Tyson Foods, Inc. (NYSE: TSN) will release its first-quarter 2026 financial results on Monday, February 2, 2026. Management will host a conference call and webcast at 9:00 a.m. Eastern Time (8:00 a.m. Central Time) to discuss the results. A replay of the webcast and audio will be available online and via telephone until Monday, March 2, 2026.

**3. Hormel Foods Reinvents the Center of the Plate: How a Legacy Brand Is Turning Pantry Staples into a**
- Source: AD HOC NEWS | 20260105T222700 | Neutral | Relevance: 73%
- Hormel Foods is transforming from a traditional canned-meat company into a diverse protein and snacking platform, focusing on convenience, premiumization, and healthier options. The company is strategically diversifying its brand portfolio, which includes Spam, Skippy, Planters, and Applegate, to cater to varying consumer needs from value-driven to health-conscious. This reinvention aims to solidify its competitive edge in a crowded market by offering a comprehensive protein ecosystem to retailers and consumers.

**4. Hormel Foods Reinvents the Center of the Plate: How a Legacy Brand Is Turning Pantry Staples into a**
- Source: AD HOC NEWS | 20260105T220819 | Neutral | Relevance: 72%
- Hormel Foods is undergoing a significant transformation, evolving from a canned-meat company into a diversified protein and snacking platform. The company is focusing on convenience, premiumization, and health-forward innovation to meet changing consumer demands. By acquiring and developing a portfolio of brands like Spam, Skippy, Planters, Columbus Craft Meats, Jennie-O, and Applegate, Hormel aims to offer a broad spectrum of products that cater to various price points and dietary preferences, positioning itself as a resilient player in the volatile food industry.

**5. Bunge Global SA: The Quiet Infrastructure Powering the Worldâ€™s Food Supply Chain**
- Source: AD HOC NEWS | 20260106T013044 | Somewhat-Bullish | Relevance: 58%
- Bunge Global SA is transforming from a traditional commodity trader into a data-driven, integrated agrifood platform, positioning itself as a strategic backbone for global food production and processing. The company's core offering is evolving into a full-stack platform that combines physical infrastructure, risk management, and sustainability data, enabling reliability and traceable supply chains for food, feed, and biofuel customers. This transformation highlights Bunge's shift towards higher-margin, infrastructure-backed revenue streams, especially through its focus on oilseeds and renewable fuel feedstocks.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | Piper Sandler | $61 | $58 | +5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | Piper Sandler | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($0.00M) |
| Sells | 15 ($5.82M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 12.9% (-0.1%)
- Blackrock Inc.: 9.2% (-1.7%)
- State Street Corpora: 5.0% (+0.6%)
- Pzena Investment Man: 4.9% (+0.9%)
- Davis Selected Advis: 3.5% (+11.2%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-5.7% 5d) with bearish MACD, trend may be turning.
2. Insider selling cluster: $5.8M in recent transactions.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.33 indicates undervaluation relative to growth. Analyst sentiment positive (1 raises, avg +5%). Insider selling cluster ($5.8M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $19.8B |
| Beta | 0.47 |
| 52W Range | $50.56 - $64.36 |
| Short Interest | 3.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.33 |
| Forward P/E | 13.0 |
| Current P/E | 14.6 |
| YoY Growth | 12.6% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 1.5% to -4.2% (-5.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 8.2pp (needs >4.0% for momentum thesis). AM_20 at -3.3% indicates price below own 20MA trend. Long-term uptrend intact (above SMA200 at 1.00x) but short-term weakness (below SMA20). RSI neutral at 43. OFD pattern: +SUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -4.24% (CS: 13) | Weak |
| RSI_14 | 43.2 | Neutral |
| MACD Histogram | -0.43 | Bearish |
| vs SMA20 | 0.967x | Below |
| vs SMA50 | 1.007x | Above |
| vs SMA200 | 1.003x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $56.22
- **Stop Loss:** $54.16 (3.7% risk)
- **Target:** $60.34 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 242
- **Position Value:** $13,605.24
- **Portfolio %:** 13.61%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with balanced risk appetite. VIX at 15.38 sits in the normal range (18th percentile of 52-week) with modest upward drift, while yield curve remains positively sloped (+62bps 10Y-3M) supporting risk assets. Breadth at 59.5% shows healthy participation, though elevated put/call ratio (1.12) suggests some hedging activity. FOMC 20 days out provides runway for current conditions to persist.*

### Earnings

**Next:** 2026-02-02 (Est: $0.95)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.83 | $1.15 | +37.8% |
| 2025Q2 | $0.78 | $0.91 | +16.2% |
| 2025Q1 | $0.82 | $0.92 | +12.2% |
| 2024Q4 | $0.88 | $1.14 | +29.9% |

---
*RULE-based L3 | 2026-01-08 08:02 | MRS_20*